1991
DOI: 10.1016/0732-8893(91)90065-n
|View full text |Cite
|
Sign up to set email alerts
|

Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

1992
1992
1993
1993

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 13 publications
0
7
0
Order By: Relevance
“…In several studies, other 1-lactams such as cefmetazole (26), cefotetan (59), and cefuroxime (40) showed diminished in vitro potency for CMRNG compared with penicillin-susceptible strains. In some cases, there was a weaker association between the MIC of penicillin and those of spectinomycin and tetracycline (61).…”
Section: Benefits and Problems Of Astmentioning
confidence: 99%
See 1 more Smart Citation
“…In several studies, other 1-lactams such as cefmetazole (26), cefotetan (59), and cefuroxime (40) showed diminished in vitro potency for CMRNG compared with penicillin-susceptible strains. In some cases, there was a weaker association between the MIC of penicillin and those of spectinomycin and tetracycline (61).…”
Section: Benefits and Problems Of Astmentioning
confidence: 99%
“…There is ample evidence that gonococcal AST has been and continues to be consistent and reliable despite minor variations in recommended test conditions. With a commercial, prepared agar medium for disk diffusion testing available and with the careful determination of quality control parameters assembled by large multicenter studies (57,58,105), it will be interesting to see whether clinical laboratories will rise to the challenge and begin to determine more antimicrobial susceptibilities for their isolates of N. gonorrhoeae.…”
Section: Cephalosporinsmentioning
confidence: 99%
“…The Working Group developed disk diffusion and agar dilution procedures, interpretive susceptibility breakpoints, and guidelines for laboratory control strains (N. gonorrhoeae ATCC 49226, N. gonorrhoeae WHO V, and Staphylococcus aureus ATCC 25923) initially for penicillin, spectinomycin, tetracycline, and ceftriaxone (12). Subsequent criteria have been published and accepted by the NCCLS for cefotaxime, ceftazidime, cefuroxime, cefoxitin, and cefixime (11,13). Table 1 summarizes the mean MICs and the MIC ranges for each of the tested drugs for both the SEA and the SD strains.…”
Section: Resultsmentioning
confidence: 99%
“…Susceptibility breakpoints were the only categories proposed for ceftriaxone and cefotaxime by Jones et al (12,13) because of the absence of resistant strains. The susceptibility breakpoints (MIC [zone diameter]) for ceftriaxone and cefotaxime were set at .0.25 ,ug/ml (>35 mm) and c0.5 ug/ml (.31 mm), respectively.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation